LINZESS

Serial Number 85773175
Registration 4614364
800

Registration Progress

Application Filed
Nov 6, 2012
Under Examination
Jan 7, 2014
Approved for Publication
Nov 12, 2013
Published for Opposition
Nov 12, 2013
Registered
Sep 30, 2014

Trademark Image

LINZESS

Basic Information

Serial Number
85773175
Registration Number
4614364
Filing Date
November 6, 2012
Registration Date
September 30, 2014
Published for Opposition
November 12, 2013
Renewal Date
September 30, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
800
Status Date
Jan 7, 2025
Registration
Registered
Classes
005 016 044

Rights Holder

Ironwood Pharmaceuticals, Inc.

03
Address
100 Summer Street, Suite 2300
Boston, MA 02110

Ownership History

Ironwood Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Ironwood Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Ironwood Pharmaceuticals, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
John V. Hobgood, Esquire

USPTO Deadlines

Next Deadline
3367 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2014-09-30)
Due Date
September 30, 2034
Grace Period Ends
March 30, 2035

Application History

45 events
Date Code Type Description
Jan 7, 2025 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 7, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 7, 2025 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 7, 2025 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 19, 2024 E89R I TEAS SECTION 8 & 9 RECEIVED
Sep 30, 2023 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 26, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 26, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 26, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 26, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 26, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 26, 2021 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 11, 2020 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 11, 2020 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 9, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 28, 2020 E815 I TEAS SECTION 8 & 15 RECEIVED
Sep 30, 2019 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 30, 2014 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 29, 2014 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 28, 2014 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 7, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 6, 2014 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Aug 6, 2014 EX1G S SOU EXTENSION 1 GRANTED
Aug 4, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 7, 2014 IUAF S USE AMENDMENT FILED
Jul 7, 2014 EXT1 S SOU EXTENSION 1 FILED
Jul 7, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 7, 2014 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 7, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2013 PUBO A PUBLISHED FOR OPPOSITION
Oct 23, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 9, 2013 ALIE A ASSIGNED TO LIE
Oct 9, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 26, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2013 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 11, 2013 GNRT F NON-FINAL ACTION E-MAILED
Mar 11, 2013 CNRT R NON-FINAL ACTION WRITTEN
Mar 4, 2013 DOCK D ASSIGNED TO EXAMINER
Nov 14, 2012 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED
Nov 13, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2012 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for use in the treatment of chronic constipation, irritable bowel syndrome [, gastrointestinal motility disorders and other gastrointestinal disorders ]
First Use Anywhere: Nov 26, 2012
First Use in Commerce: Nov 26, 2012
Class 016
printed matter, namely, brochures, pamphlets, patient educational materials, all concerning the treatment of chronic constipation, irritable bowel syndrome [, gastrointestinal motility disorders and other gastrointestinal disorders ]
First Use Anywhere: Dec 14, 2012
First Use in Commerce: Dec 14, 2012
Class 044
medical informational services, namely, providing health information in the field of chronic constipation, irritable bowel syndrome [, gastrointestinal motility disorders and other gastrointestinal disorders via a global computer network ]
First Use Anywhere: Sep 4, 2012
First Use in Commerce: Sep 4, 2012

Additional Information

Design Mark
The mark consists of the word "LINZESS" in blue with three curved bands in purple, orange and blue joined at an orange circle positioned to the upper right of the word.
Color Claim
The color(s) blue, purple and orange is/are claimed as a feature of the mark.

Classification

International Classes
005 016 044